Survival in smouldering myeloma and symptomatic myeloma: Is there an emerging Will Rogers phenomenon?

被引:5
作者
Chakraborty, Rajshekhar [1 ]
机构
[1] Columbia Univ, Irving Med Ctr, Herbert Irving Comprehens Canc Ctr, New York, NY 10027 USA
关键词
D O I
10.1016/j.ejca.2022.05.041
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:234 / 236
页数:3
相关论文
共 12 条
[1]   Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Siltuximab in High-Risk Smoldering Multiple Myeloma [J].
Brighton, Timothy A. ;
Khot, Amit ;
Harrison, Simon J. ;
Ghez, David ;
Weiss, Brendan M. ;
Kirsch, Andres ;
Magen, Hila ;
Gironella, Mercedes ;
Oriol, Albert ;
Streetly, Matthew ;
Kranenburg, Britte ;
Qin, Xiang ;
Bandekar, Rajesh ;
Hu, Peter ;
Guilfoyle, Mary ;
Qi, Ming ;
Nemat, Sepideh ;
Goldschmidt, Hartmut .
CLINICAL CANCER RESEARCH, 2019, 25 (13) :3772-3775
[2]   THE ROGERS,WILL PHENOMENON - STAGE MIGRATION AND NEW DIAGNOSTIC-TECHNIQUES AS A SOURCE OF MISLEADING STATISTICS FOR SURVIVAL IN CANCER [J].
FEINSTEIN, AR ;
SOSIN, DM ;
WELLS, CK .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (25) :1604-1608
[3]   The Impact of S-Li-M Criteria in Myeloma in a Real-Life Population: Patient & Disease Characteristics, Treatment and Outcomes from the Australian and New Zealand Myeloma and Related Diseases Registry (MRDR) [J].
Ho, Phoebe Joy ;
Moore, Elizabeth M. ;
Wellard, Cameron ;
Quach, Hang ;
Blacklock, Hilary ;
Harrison, Simon J. ;
McDonald, Emma-Jane ;
McQuilten, Zoe ;
Wood, Erica M. ;
Mollee, Peter ;
Spencer, Andrew .
BLOOD, 2020, 136
[4]   The prognostic importance of the presence of more than one focal lesion in spine MRI of patients with asymptomatic (smoldering) multiple myeloma [J].
Kastritis, E. ;
Moulopoulos, L. A. ;
Terpos, E. ;
Koutoulidis, V. ;
Dimopoulos, M. A. .
LEUKEMIA, 2014, 28 (12) :2402-2403
[5]  
Kastritis E, 2021, BLOOD, V138, P1636
[6]   Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma [J].
Kyle, Robert A. ;
Remstein, Ellen D. ;
Therneau, Terry M. ;
Dispenzieri, Angela ;
Kurtin, Paul J. ;
Hodnefield, Janice M. ;
Larson, Dirk R. ;
Plevak, Matthew F. ;
Jelinek, Diane F. ;
Fonseca, Rafael ;
Melton, Lee Joseph, III ;
Rajkumar, S. Vincent .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (25) :2582-2590
[7]   Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteria [J].
Lakshman, Arjun ;
Rajkumar, S. Vincent ;
Buadi, Francis K. ;
Binder, Moritz ;
Gertz, Morie A. ;
Lacy, Martha Q. ;
Dispenzieri, Angela ;
Dingli, David ;
Fonder, Amie L. ;
Hayman, Suzanne R. ;
Hobbs, Miriam A. ;
Gonsalves, Wilson I. ;
Hwa, Yi Lisa ;
Kapoor, Prashant ;
Leung, Nelson ;
Go, Ronald S. ;
Lin, Yi ;
Kourelis, Taxiarchis V. ;
Warsame, Rahma ;
Lust, John A. ;
Russell, Stephen J. ;
Zeldenrust, Steven R. ;
Kyle, Robert A. ;
Kumar, Shaji K. .
BLOOD CANCER JOURNAL, 2018, 8
[8]   Serum free light chain ratio as a biomarker for high-risk smoldering multiple myeloma [J].
Larsen, J. T. ;
Kumar, S. K. ;
Dispenzieri, A. ;
Kyle, R. A. ;
Katzmann, J. A. ;
Rajkumar, S. V. .
LEUKEMIA, 2013, 27 (04) :941-946
[9]   Randomized Trial of Lenalidomide Versus Observation in Smoldering Multiple Myeloma [J].
Lonial, Sagar ;
Jacobus, Susanna ;
Fonseca, Rafael ;
Weiss, Matthias ;
Kumar, Shaji ;
Orlowski, Robert Z. ;
Kaufman, Jonathan L. ;
Yacoub, Abdulraheem M. ;
Buadi, Francis K. ;
O'Brien, Timothy ;
Matous, Jeffrey V. ;
Anderson, Daniel M. ;
Emmons, Robert V. ;
Mahindra, Anuj ;
Wagner, Lynne I. ;
Dhodapkar, Madhav V. ;
Rajkumar, S. Vincent .
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (11) :1126-+
[10]   Lenalidomide plus Dexamethasone for High-Risk Smoldering Multiple Myeloma [J].
Mateos, Maria-Victoria ;
Hernandez, Miguel-Teodoro ;
Giraldo, Pilar ;
de la Rubia, Javier ;
de Arriba, Felipe ;
Lopez Corral, Lucia ;
Rosinol, Laura ;
Paiva, Bruno ;
Palomera, Luis ;
Bargay, Joan ;
Oriol, Albert ;
Prosper, Felipe ;
Lopez, Javier ;
Olavarria, Eduardo ;
Quintana, Nuria ;
Garcia, Jose-Luis ;
Blade, Joan ;
Lahuerta, Juan-Jose ;
San Miguel, Jesus-F. .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (05) :438-447